Related Experiment Video
Updated: Jul 31, 2025

10:20
Generation of a Human iPSC-Based Blood-Brain Barrier Chip
Published on: March 2, 2020
12.7K
Microfluidic 'brain-on chip' systems to supplement neurological practice: development, applications and
Ryan Jarrah1, Karim Rizwan Nathani1, Shaan Bhandarkar2
1Department of Neurosurgery, Mayo Clinic, Rochester, MN 55905, USA.
Regenerative Medicine
|May 1, 2023
Summary
Brain-on-chip (BoC) microfluidic devices offer advanced models for studying neurological diseases like Alzheimer's and epilepsy. These powerful tools aid in understanding complex pathologies and improving drug testing for regenerative medicine.
Area of Science:
- Bioengineering
- Tissue Engineering
- Neuroscience
Background:
- Mimicking human physiology is a key challenge in bioengineering.
- Sophisticated brain-on-chip (BoC) microfluidic devices are emerging tools in tissue engineering.
- BoC devices can replicate structural and functional aspects of brain tissue.
Purpose of the Study:
- To evaluate the potential of microfluidic BoC devices for modeling neurological pathologies.
- To explore the application of BoC technology in understanding disease mechanisms and testing therapeutics.
- To discuss the principles, limitations, and future directions of BoC technology.
Main Methods:
- Utilized microfluidic brain-on-chip devices.
- Evaluated BoC models for neurological conditions including Alzheimer's, glioblastoma, traumatic brain injury, stroke, and epilepsy.
- Discussed the underlying principles and practical challenges of BoC implementation.
Main Results:
- BoC models demonstrate potential in understanding complex neurological pathologies.
- These models can enhance drug testing for regenerative medicine applications.
- The study identified practical limitations hindering the clinical translation of organ-on-chip technology.
Conclusions:
- Brain-on-chip technology is a versatile tool for advancing neurological disease research.
- BoC devices can broaden understanding of pathophysiological and therapeutic uncertainties in neurological disorders.
- Further attention is needed to address limitations for large-scale clinical applicability.

